Career history of Harald Petry
Former positions of Harald Petry
Companies | Position | Start | End |
---|---|---|---|
UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 2012-01-08 | 2017-08-06 |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Chief Tech/Sci/R&D Officer | 2010-06-22 | 2013-03-10 |
Berlex Biosciences | Corporate Officer/Principal | - | - |
Jenapharm GmbH & Co. KG
Jenapharm GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Jenapharm GmbH & Co. KG manufactures and distributes pharmaceutical products. It offers cures for erectile dysfunction, testosterone deficit, and hyperactivity. It also provides contraceptives, menopause pills, and food supplements. The company was founded in 1950 and is headquartered in Jena, Germany. | Corporate Officer/Principal | - | - |
Training of Harald Petry
University of Giessen | Doctorate Degree |
Statistics
International
Germany | 3 |
Netherlands | 3 |
United States | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
UNIQURE N.V. | Health Technology |
Private companies | 3 |
---|---|
Jenapharm GmbH & Co. KG
Jenapharm GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Jenapharm GmbH & Co. KG manufactures and distributes pharmaceutical products. It offers cures for erectile dysfunction, testosterone deficit, and hyperactivity. It also provides contraceptives, menopause pills, and food supplements. The company was founded in 1950 and is headquartered in Jena, Germany. | Health Technology |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
Berlex Biosciences |
- Stock Market
- Insiders
- Harald Petry
- Experience